| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumors. | Ann Oncol | 2009 | 1.04 |
| 2 | A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines. | Ann Oncol | 2008 | 1.01 |
| 3 | Weekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with refractory solid tumours: results of a phase I trial. | Br J Cancer | 2009 | 1.00 |
| 4 | Current treatment of mantle cell lymphoma: results of a national survey and consensus meeting. | Ann Hematol | 2012 | 0.77 |